SECOND AMENDMENT TO PATENT TRANSFER AGREEMENT
Exhibit 10.1
SECOND AMENDMENT TO PATENT TRANSFER AGREEMENT
THIS IS A SECOND AMENDMENT, dated as of May 15, 2008, to that certain PATENT TRANSFER AGREEMENT dated as of May 11, 2005 (the “Patent Transfer Agreement”) by and between Bayer Schering Pharma AG, a German corporation having its principal place of business in Xxxxxxxxxxxx 000, 00000 Xxxxxx, Xxxxxxx (hereinafter referred to as “BSP”) and Acusphere, Inc., a Delaware corporation having its place of business at 000 Xxxxxxx Xxxxxx, Xxxxxxxxx, XX 00000, XXX (hereinafter referred to as “Acusphere”)
WHEREAS, BSP (formerly acting under the name Schering Aktiengesellschaft) and Acusphere entered into the Patent Transfer Agreement on May 11, 2005, pursuant to which certain patent rights were transferred from BSP to Acusphere;
WHEREAS, under an Amendment to the Patent Transfer Agreement dated April 27, 2007 (the “First Amendment”) Acusphere will be obligated to make a payment of $1,000,000 to BSP on or before fifteen days after May 11, 2008 and a payment of another $1,000,000 to BSP on or before fifteen days after May 11, 2009;
WHEREAS, Acusphere wishes to defer payment of such May 11, 2008 payment and BSP is willing to agree to a deferral on the terms set forth herein;
NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows:
1. Notwithstanding anything to the contrary contained in the First Amendment, rather than the second $2,000,000 payment payable under Section 1.b and 1.c of the First Amendment, Acusphere shall instead pay BSP a total of $2,000,000 as follows:
a. $200,000 on or before fifteen days after the execution of this Amendment;
b. $1,800,000 on or before fifteen days after May 11, 2009; and
2. In all other respects, the Patent Transfer Agreement shall remain in effect as executed.
IN WITNESS WHEREOF, the parties have executed this Amendment to Patent Transfer Agreement as of the date first above written.
ACUSPHERE, INC.
|
BY |
/s/ Xxxxxx X. Xxxxx |
|
|
|
|
|
|
|
|
|
|
|
|
|
BAYER SCHERING PHARMA AG |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BY |
/s/ Xx. Xxxx Xxxxx |
|
/s/ Xx. Xxxxxx Xxxx |
|
|
Xx. Xxxx Xxxxx |
|
Xx. Xxxxxx Xxxx |
